AFM studied the effect of celastrol on β1 integrin-mediated HUVEC adhesion and migration

Scanning

Volumn 35, Issue 5, 2013, Pages 316-326

  Ke, Changhong ^a   Jin, Hua ^a   Cai, Jiye ^a  

^a JINAN UNIVERSITY   (China)

Author keywords

AFM; antiangiogenesis HUVEC; integrin beta 1; migration

Indexed keywords

AFM; ANTIANGIOGENESIS; HIGH-RESOLUTION IMAGING; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; INTEGRINS; MIGRATION; TRADITIONAL CHINESE MEDICINE; TUMOR-INDUCED ANGIOGENESIS;

ATOMIC FORCE MICROSCOPY; CELL ADHESION; CELL MEMBRANES; ENDOTHELIAL CELLS; IMAGE RECONSTRUCTION; PROTEINS;

TUMORS;

ACTIN; BETA1 INTEGRIN; CELASTROL; FIBRONECTIN; NANOMATERIAL; POLYLYSINE; ANTINEOPLASTIC AGENT; TRIPTERINE; TRITERPENE;

ANTIANGIOGENIC ACTIVITY; ARTICLE; ATOMIC FORCE MICROSCOPE; CANCER INHIBITION; CELL ADHESION; CELL MIGRATION; CELL STRUCTURE; CELL SURFACE; CELL ULTRASTRUCTURE; CONTROLLED STUDY; CYTOSKELETON; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MICROSCOPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; WOUND HEALING; ATOMIC FORCE MICROSCOPY; CELL MEMBRANE; CELL MOTION; CELL SHAPE; DRUG EFFECTS; ENDOTHELIUM CELL; METABOLISM; PHYSIOLOGY; SURFACE PROPERTY; ULTRASTRUCTURE;

ANTIGENS, CD29; ANTINEOPLASTIC AGENTS; CELL ADHESION; CELL MEMBRANE; CELL MOVEMENT; CELL SHAPE; ENDOTHELIAL CELLS; FIBRONECTINS; HUMANS; MICROSCOPY, ATOMIC FORCE; SURFACE PROPERTIES; TRITERPENES;

EID: 84886095596     PISSN: 01610457     EISSN: 19328745     Source Type: Journal    
DOI: 10.1002/sca.21070     Document Type: Article

References (34)

1. Bass R, Fernandez AMM, Ellis V,. 2002. Maspin inhibits cell migration in the absence of protease inhibitory activity. J Biol Chem 277: 46845-46848.
2. Boosani CS, Mannam AP, Cosgrove D, Silva R, Hodivala-Dilke KM, Keshamouni VG, Sudhakar A,. 2007. Regulation of COX-2 mediated signaling by 3 type IV noncollagenous domain in tumor angiogenesis. Blood 110: 1168-1177.
3. Cai X, Xing X, Cai J, Chen Q, Wu S, Huang F,. 2010. Connection between biomechanics and cytoskeleton structure of lymphocyte and Jurkat cells: an AFM study. Micron 41: 257-262.
4. Carragher NO, Frame MC,. 2004. Focal adhesion and actin dynamics: a place where kinases and proteases meet to promote invasion. Trends Cell Biol 14: 241-249.
5. Chadli A, Felts SJ, Wang Q, Sullivan WP, Botuyan MV, Fauq A, Ramirez-Alvarado M, Mer G,. 2010. Celastrol inhibits Hsp90 chaperoning of steroid receptors by inducing fibrillization of the Co-chaperone p23. J Biol Chem 285: 4224-4231.
6. Chen M, Rose AE, Doudican N, Osman I, Orlow SJ,. 2009. Celastrol synergistically enhances temozolomide cytotoxicity in melanoma cells. Mol Can Res 7: 1946-1953.
7. Fletcher DA, Mullins RD,. 2010. Cell mechanics and the cytoskeleton. Nature 463: 485-492.
8. Francis SE,. 2002. Central roles of alpha5beta1 integrin and fibronectin in vascular development in mouse embryos and embryoid bodies. Arterioscler Thromb Vasc Biol 22: 927-933.
9. Giancotti FG,. 1999. Integrin signaling. Science 285: 1028-1033.
10. Hosseini BH, Louban I, Djandji D, Wabnitz GH, Deeg J, Bulbuc N, Samstag Y, Gunzer M, Spatz JP, Hammerling GJ,. 2009. Immune synapse formation determines interaction forces between T cells and antigen-presenting cells measured by atomic force microscopy. Proc Natl Acad Sci USA 106: 17852-17857.
11. Jin H, Ma S, Song B, Ma L, Pi J, Chen X, Chen Y, Cai J,. 2011. Liposome impaired the adhesion and spreading of HEK293 cells: an AFM study. Scanning 33: 413-418.
12. Jung SH, Park D, Park JH, Kim YM, Ha KS,. 2010. Molecular imaging of membrane proteins and microfilaments using atomic force microscopy. Exp Mol Med 42: 597-605.
13. Kataoka N, Iwaki K, Hashimoto K, Mochizuki S, Ogasawara Y, Sato M, Tsujioka K, Kajiya F,. 2002. Measurements of endothelial cell-to-cell and cell-to-substrate gaps and micromechanical properties of endothelial cells during monocyte adhesion. Proc Natl Acad Sci USA 99: 15638-15643.
14. Katz M, Amit I, Citri A, Shay T, Carvalho S, Lavi S, Milanezi F, Lyass L, Amariglio N, Jacob-Hirsch J, Ben-Chetrit N, Tarcic G, Lindzen M, Avraham R, Liao YC, Trusk P, Lyass A, Rechavi G, Spector NL, Lo SH, Schmitt F, Bacus SS, Yarden Y,. 2007. A reciprocal tensin-3-cten switch mediates EGF-driven mammary cell migration. Nat Cell Biol 9: 961-969.
15. Ke CH, Peng Y, Chen W, Cai J,. 2011. AFM study of the celastrol-induced inhibition on vein endothelial cells. Biotechnology 21: 61-66.
16. Laurent VM, Kasas S, Yersin A, Schäffer TE, Catsicas S, Dietler G, Verkhovsky AB, Meister JJ,. 2005. Gradient of rigidity in the lamellipodia of migrating cells revealed by atomic force microscopy. Biophys J 89: 667-675.
17. Lekka M, Laidler P,. 2009. Applicability of AFM in cancer detection. Nat Nanotechnol 4: 72-73.
18. Malan D, Wenzel D, Schmidt A, Geisen C, Raible A, Bolck B, Fleischmann BK, Bloch W,. 2010. Endothelial beta 1 integrins regulate sprouting and network formation during vascular development. Development 137: 993-1002.
19. Minamiguchi K, Kumagai H, Masuda T, Kawada M, Ishizuka M, Takeuchi T,. 2001. Thiolutin, an inhibitor of HUVEC adhesion to vitronectin, reduces paxillin in HUVECs and suppresses tumor cell-induced angiogenesis. Int J Can 93: 307-316.
20. Murakami M, Simons M,. 2009. Regulation of vascular integrity. J Mol Med 87: 571-582.
21. Nagayama M, Haga H, Kawabata K,. 2001. Drastic change of local stiffness distribution correlating to cell migration in living fibroblasts. Cell Motil Cytoskeleton 50: 173-179.
22. Niland S, Eble JA,. 2012. Integrin-mediated cell-matrix interaction in physiological and pathological blood vessel formation. J Oncol 2012: 1-25.
23. Pang X, Yi Z, Zhang J, Lu B, Sung B, Qu W, Aggarwal BB, Liu M,. 2010. Celastrol suppresses angiogenesis-mediated tumor growth through inhibition of AKT/mammalian target of rapamycin pathway. Can Res 70: 1951-1959.
24. Pang X, Yi Z, Zhang X, Sung B, Qu W, Lian X, Aggarwal BB, Liu M,. 2009. Acetyl-11-keto-beta-boswellic acid inhibits prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis. Can Res 69: 5893-5900.
25. Peng B, Xu L, Cao F, Wei T, Yang C, Uzan G, Zhang D,. 2010. HSP90 inhibitor, celastrol, arrests human monocytic leukemia cell U937 at G0/G1 in thiol-containing agents reversible way. Mol Can 9: 79.
26. Pezzatini S, Morbidelli L, Solito R, Paccagnini E, Boanini E, Bigi A, Ziche M,. 2007. Nanostructured HA crystals up-regulate FGF-2 expression and activity in microvascular endothelium promoting angiogenesis. Bone 41: 523-534.
27. Pozzi A, Zent R,. 2003. Integrins: sensors of extracellular matrix and modulators of cell function. Nephron Exp Nephrol 94: e77-e84.
28. Qin L, Zhang M,. 2010. Maspin regulates endothelial cell adhesion and migration through an integrin signaling pathway. J Biol Chem 285: 32360-32369.
29. Senger DR, Perruzzi CA, Streit M, Koteliansky VE, de Fougerolles AR, Detmar M,. 2002. The alpha(1)beta(1) and alpha(2)beta(1) integrins provide critical support for vascular endothelial growth factor signaling, endothelial cell migration, and tumor angiogenesis. Am J Pathol 160: 195-204.
30. Silva R, D'Amico G, Hodivala-Dilke KM, Reynolds LE,. 2008. Integrins: the keys to unlocking angiogenesis. Arterioscler Thromb Vasc Biol 28: 1703-1713.
31. Sun Z, Li X, Massena S, Kutschera S, Padhan N, Gualandi L, Sundvold-Gjerstad V, Gustafsson K, Choy WW, Zang G, Quach M, Jansson L, Phillipson M, Abid MR, Spurkland A, Claesson-Welsh L,. 2012. VEGFR2 induces c-SRC signaling and vascular permeability in vivo via the adaptor protein TSAd. J Exp Med 209: 1363-1377.
32. Wang M, Ruan Y, Xing X, Chen Q, Peng Y, Cai J,. 2011. Curcumin induced nanoscale CD44 molecular redistribution and antigen-antibody interaction on HepG2 cell surface. Analytica Chimica Acta 697: 83-89.
33. Zhou J, Chen Y, Lang JY, Lu JJ, Ding J,. 2008. Salvicine inactivates beta 1 integrin and inhibits adhesion of MDA-MB-435 cells to fibronectin via reactive oxygen species signaling. Mol Can Res 6: 194-204.
34. Zhu H, Liu XW, Cai TY, Cao J, Tu CX, Lu W, He QJ, Yang B,. 2010. Celastrol acts as a potent antimetastatic agent targeting 1 integrin and inhibiting cell-extracellular matrix adhesion, in part via the p38 mitogen-activated protein kinase pathway. J Pharmacol Exp Ther 334: 489-499.